[Change and significance of Th17 cells and its secretive IL-17 in patients with autoimmune hemolytic anemia].
To observe the percentage of Th17 cells in the peripheral blood and levels of plasma IL-17 of patients with autoimmune hemolytic anemia (AIHA)before treatment and after glucocorticoid treatment and to explore their clinical significance. Flow cytometric assay were used to detect the rate of Th17 cells in AIHA patients. The level of plasma IL-17 in AIHA patients were measured by ELISA. The rate of Th17 cells and the level of plasma IL-17 were significantly increased before treatment as compared with that in normal controls [(2.78 ± 0.59)%, (126.4 ± 11.6)ng/L vs (0.59 ± 0.15)%, (52.3 ± 4.8) ng/L](P < 0.01). After treatment, The percentage of Th17 cells (1.05±0.28)% was significantly decreased (P < 0.01). The same tendency was also found in the levels of plasma IL-17(78.5 ± 6.4) ng/L(P < 0.01). The rate of Th17 cells and the lever of plasma IL-17 significantly elevate in AIHA patients. Glucocorticoid might play a role in AIHA treatment by down-regulating Th17 cells number and concentrations of IL-17.